Unity Biotechnology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MAYO CLINIC | 02/09/2023 | 157,198 | $430,723 | 100.00% | 1.66% |
| ROSENBERG MATTHEW HAMILTON | 01/19/2023 | 200 | $548 | -90.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| US BANCORP \DE\ | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| FRANKLIN RESOURCES INC | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| BAILARD, INC. | 02/02/2023 | 0 | $0 | -100.00% | 0.00% |
| CLEARSTEAD ADVISORS, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/09/2023 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| CANTOR FITZGERALD, L. P. | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 04/25/2023 | 0 | $0 | -100.00% | 0.00% |
| FEDERATED HERMES, INC. | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| BAILLIE GIFFORD & CO | 03/10/2023 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| UBS OCONNOR LLC | 08/14/2023 | 0 | $0 | -100.00% | 0.00% |
| PRUDENTIAL FINANCIAL INC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| MARINER, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| LAURION CAPITAL MANAGEMENT LP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 02/07/2023 | 0 | $0 | -100.00% | 0.00% |
| 683 CAPITAL MANAGEMENT, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| SIGNATUREFD, LLC | 01/30/2023 | 0 | $0 | -100.00% | 0.00% |
| HAP TRADING, LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/02/2023 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/15/2023 | 0 | $0 | -100.00% | 0.00% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 01/31/2023 | 0 | $0 | -100.00% | 0.00% |
| CREATIVE PLANNING | 02/10/2023 | 0 | $0 | -100.00% | 0.00% |
| BUCKINGHAM STRATEGIC WEALTH, LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| EQIS CAPITAL MANAGEMENT, INC. | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
Unity Biotechnology, Inc.institutional Ownership - FAQ's
During the previous two years, 11 institutional investors and hedge funds held shares of Unity Biotechnology, Inc.. The most heavily invested institutionals were:
Empery Asset Management, LP: 4.41 M
Corbenic Partners LLC: 0
Arbor Wealth Management, LLC: 0
Marshall Wace North America L.P.: 14,397
20/20 Capital Management, Inc.: 42,840
SUNFLOWER BANK, NA WEALTH MANAGEMENT: 0
1.66% of Unity Biotechnology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.59 M shares in the last 24 months. This purchase volume represents approximately $4.59 M in transactions.